BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30778297)

  • 1. Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders.
    Vasconcelos AR; Dos Santos NB; Scavone C; Munhoz CD
    Front Pharmacol; 2019; 10():33. PubMed ID: 30778297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
    Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
    Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases.
    Sun Y; Yang T; Leak RK; Chen J; Zhang F
    CNS Neurol Disord Drug Targets; 2017; 16(3):326-338. PubMed ID: 28042770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.
    Villavicencio Tejo F; Quintanilla RA
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases.
    Fão L; Mota SI; Rego AC
    Ageing Res Rev; 2019 Sep; 54():100942. PubMed ID: 31415806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
    Prasad KN
    J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
    Sivandzade F; Bhalerao A; Cucullo L
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress-elicited YY1 potentiates antioxidative response via enhancement of NRF2-driven transcriptional activity: A potential neuronal defensive mechanism against ischemia/reperfusion cerebral injury.
    Liu W; Guo Q; Zhao H
    Biomed Pharmacother; 2018 Dec; 108():698-706. PubMed ID: 30248537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death.
    Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK
    CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eriodictyol-7-O-glucoside activates Nrf2 and protects against cerebral ischemic injury.
    Jing X; Ren D; Wei X; Shi H; Zhang X; Perez RG; Lou H; Lou H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):672-9. PubMed ID: 24466583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
    Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
    Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
    Liddell JR
    Antioxidants (Basel); 2017 Aug; 6(3):. PubMed ID: 28820437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gualou Guizhi Granule Protects Against Oxidative Injury by Activating Nrf2/ARE Pathway in Rats and PC12 Cells.
    Zhang Y; Fan L; Li H; Wang X; Xu W; Chu K; Lin Y
    Neurochem Res; 2018 May; 43(5):1003-1009. PubMed ID: 29564698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric Acid Protects against Focal Cerebral Ischemia/Reperfusion-Induced Oxidative Stress via Activating Nrf2 and Regulating Neurotrophic Factor Expression.
    Ya BL; Liu Q; Li HF; Cheng HJ; Yu T; Chen L; Wang Y; Yuan LL; Li WJ; Liu WY; Bai B
    Oxid Med Cell Longev; 2018; 2018():6069150. PubMed ID: 30581534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.